Hubei Gedian Humanwell Pharmaceutical Testosterone Enanthate Hubei Gedian Humanwell Pharmaceutical Testosterone Enanthate

X

Find Radio Compass News for Testosterone Enanthate

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
389
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

0

Canada

Canada

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

JP

0

Other Listed Suppliers

SERVICES

0

https://www.businesswire.com/news/home/20231002698068/en

BUSINESSWIRE
10 Oct 2023

https://www.businesswire.com/news/home/20230308005585/en

BUSINESSWIRE
20 Mar 2023

https://pharmaphorum.com/news/scottish-medicines-consortium-accepts-theramex-bijuve-hrt/

PHARMAPHORUM
13 Sep 2022

https://www.businesswire.com/news/home/20220617005176/en

BUSINESSWIRE
17 Jun 2022

https://www.businesswire.com/news/home/20220506005347/en

BUSINESSWIRE
09 May 2022

https://www.businesswire.com/news/home/20220321005530/en

BUSINESSWIRE
21 Mar 2022

https://www.businesswire.com/news/home/20220214005409/en

BUSINESSWIRE
14 Feb 2022

https://www.businesswire.com/news/home/20220210005899/en

BUSINESSWIRE
10 Feb 2022

https://www.businesswire.com/news/home/20211223005258/en

BUSINESSWIRE
23 Dec 2021

https://www.businesswire.com/news/home/20211223005258/en

BUSINESSWIRE
23 Dec 2021

http://www.pharmafile.com/news/595730/theramex-launches-femarelle-treat-menopause-symptoms

PHARMAFILE
16 Nov 2021

https://www.businesswire.com/news/home/20211115005063/en

BUSINESSWIRE
15 Nov 2021

https://www.businesswire.com/news/home/20211014005804/en

BUSINESSWIRE
14 Oct 2021

https://www.raps.org/news-and-articles/news-articles/2021/10/euro-roundup-prac-starts-reviewing-risk-of-tumors

Nick Paul Taylor RAPS
07 Oct 2021

http://www.pharmafile.com/news/588612/theramex-pioneers-new-treatment-post-menopausal-women

PHARMAFILE
24 Sep 2021

https://www.businesswire.com/news/home/20210921006102/fr

BUSINESSWIRE
21 Sep 2021

https://www.businesswire.com/news/home/20210712005463/en

BUSINESSWIRE
12 Jul 2021

https://www.bigmoleculewatch.com/2021/06/14/theramex-announces-license-agreement-for-prolia-biosimilar-in-europe-and-australia/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+goodwinprocter-bigmoleculewatchblog+%28Big+Molecule+Watch+Blog+%7C+Goodwin%29

Audie Soucy GOODWIN
14 Jun 2021

https://www.pharmiweb.com/press-release/2021-06-10/theramex-uk-ltd-announces-a-license-and-supply-agreement-with-enzene-biosciences-limited-for-the-registration-and-commercialisation-of-denosumab-an

PHARMIWEB
10 Jun 2021

https://www.pharmiweb.com/press-release/2021-01-18/theramex-launches-livogiva-a-new-teriparatide-pre-filled-pen-for-the-treatment-of-severe-osteoporosis

PHARMIWEB
19 Jan 2021

http://www.pharmafile.com/news/569122/theramex-launches-osteoporosis-drug-livogiva-europe

PHARMAFILE
18 Jan 2021

https://www.prnewswire.com/news-releases/quest-diagnostics-acquires-blueprint-genetics-to-broaden-access-to-actionable-insights-for-genetic-and-rare-diseases-300990571.html

PR NEWSWIRE
23 Jan 2020

https://globenewswire.com/news-release/2018/04/05/1465578/0/en/Antares-Pharma-Provides-XYOSTED-Regulatory-Update.html

GLOBENEWSWIRE
05 Apr 2018
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY